Japan Tissue Engineering Co Ltd
TSE:7774
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Japan Tissue Engineering Co Ltd
Inventory
Japan Tissue Engineering Co Ltd
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Inventory
¥244.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
|
SanBio Co Ltd
TSE:4592
|
Inventory
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
GNI Group Ltd
TSE:2160
|
Inventory
¥3.8B
|
CAGR 3-Years
30%
|
CAGR 5-Years
32%
|
CAGR 10-Years
36%
|
|
|
PeptiDream Inc
TSE:4587
|
Inventory
¥3.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
Takara Bio Inc
TSE:4974
|
Inventory
¥12.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
|
O
|
Oncolys Biopharma Inc
TSE:4588
|
Inventory
¥3.9m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-13%
|
|
Japan Tissue Engineering Co Ltd
Glance View
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.
See Also
What is Japan Tissue Engineering Co Ltd's Inventory?
Inventory
244.5m
JPY
Based on the financial report for Dec 31, 2025, Japan Tissue Engineering Co Ltd's Inventory amounts to 244.5m JPY.
What is Japan Tissue Engineering Co Ltd's Inventory growth rate?
Inventory CAGR 10Y
5%
Over the last year, the Inventory growth was 16%. The average annual Inventory growth rates for Japan Tissue Engineering Co Ltd have been -3% over the past three years , -5% over the past five years , and 5% over the past ten years .
